Immunotherapy efficacy and gender: discovery in precision medicine

about

Immunotherapy efficacy and gender: discovery in precision medicine

Item

http://www.wikidata.org/entity/Q58562489

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Immunotherapy efficacy and gender: discovery in precision medicine

@en

Immunotherapy efficacy and gender: discovery in precision medicine

@nl

type

Item

label

Immunotherapy efficacy and gender: discovery in precision medicine

@en

Immunotherapy efficacy and gender: discovery in precision medicine

@nl

prefLabel

Immunotherapy efficacy and gender: discovery in precision medicine

@en

Immunotherapy efficacy and gender: discovery in precision medicine

@nl

P1476

Immunotherapy efficacy and gender: discovery in precision medicine

@en

P2093

Bryan C Ulrich

http://www.w3.org/2001/XMLSchema#string

Nicolas Guibert

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor Immunotherapy Directed at PD-1

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Targeting the PD1/PD-L1 axis in melanoma: biological rationale, clinical challenges and opportunities.

Gender Disparity and Mutation Burden in Metastatic Melanoma.

Analysis of ultra-deep targeted sequencing reveals mutation burden is associated with gender and clinical outcome in lung adenocarcinoma

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.

Tumor Mutational Burden and Response Rate to PD-1 Inhibition.

Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma.

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

P304

S211-S213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/TLCR.2018.08.05

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

Suppl 3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30393604

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

6193899

http://www.w3.org/2001/XMLSchema#string